What is Bloom Science?
Founded in 2017 and headquartered in San Diego, Bloom Science is a biotechnology firm dedicated to the development of microbiome therapeutics and drugs. The company's focus on this emerging field positions it at the forefront of novel treatment strategies for various health conditions.
How much funding has Bloom Science raised?
Bloom Science has raised a total of $12.1M across 2 funding rounds:
Debt
$95K
Series A
$12M
Debt (2021): $95K with participation from PPP
Series A (2021): $12M led by Apollo Ventures, ALS Investment Fund, Joyance Partners, and Bayer
Key Investors in Bloom Science
Apollo Ventures
Apollo Health Ventures is a transatlantic early-stage venture capital firm focused on investing in transformative healthcare companies that address age-related diseases and aging. The firm aims to enhance healthy lifespan and reduce healthcare spending through biotechnology innovations.
Joyance Partners
Joyance invests in companies that leverage science and technology to enhance quality of life across North America, Europe, and Asia. The firm focuses on the health and consumer sectors, targeting investments from pre-seed to Series A stages.
Bayer
Bayer is a global enterprise in the life science fields of healthcare and nutrition, with divisions in pharmaceuticals, crop science, animal health, and consumer health. They support efforts to overcome major challenges presented by a growing and aging global population.
What's next for Bloom Science?
The substantial enterprise-level backing indicates Bloom Science is likely in a scaling phase, aiming to advance its therapeutic pipeline through clinical trials and expand its operational capacity. This strategic investment will be crucial for accelerating research and development, potentially leading to the commercialization of innovative microbiome-based treatments and solidifying its market position in the competitive biotech landscape.
See full Bloom Science company page
